Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Debt / NOTE 6.000% 5/1
-
Number of holders
-
4
-
Total 13F principal, excl. options
-
102M
-
Principal change
-
+102M
-
Total reported value, excl. options
-
$79.5M
-
Value change
-
+$79.5M
-
Number of buys
-
4
-
Price
-
$0.74
Significant Holders of KARYOPHARM THERAPEUTICS INC - NOTE 6.000% 5/1 as of Q2 2025
4 filings reported holding 48576UAD8 - KARYOPHARM THERAPEUTICS INC - NOTE 6.000% 5/1 as of Q2 2025.
KARYOPHARM THERAPEUTICS INC - NOTE 6.000% 5/1 has 4 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $102M of principal
.
Largest 4 bondholders include BRAIDWELL LP ($48.5M of principal), Davidson Kempner Capital Management LP ($30M of principal), HIGHBRIDGE CAPITAL MANAGEMENT LLC ($23.6M of principal), and Context Capital Management, LLC ($8.87K of principal).
This table shows the top 4 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.